Kate Postans - ConvaTec Group VP Communications
| 2CV Stock | EUR 2.62 0.02 0.77% |
Insider
Kate Postans is VP Communications of ConvaTec Group PLC
| Address | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG |
| Phone | 44 11 8952 8100 |
| Web | https://www.convatecgroup.com |
ConvaTec Group Management Efficiency
The company has return on total asset (ROA) of 0.0643 % which means that it generated a profit of $0.0643 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.125 %, meaning that it generated $0.125 on every $100 dollars invested by stockholders. ConvaTec Group's management efficiency ratios could be used to measure how well ConvaTec Group manages its routine affairs as well as how well it operates its assets and liabilities. At this time, ConvaTec Group's Non Currrent Assets Other are most likely to increase significantly in the upcoming years.Similar Executives
| Found 13 records | INSIDER Age | ||
| Don Bailey | BIOTIME | 73 | |
| Stephen Farrell | BIOTIME | 54 | |
| Stephana Patton | BIOTIME | 48 | |
| Deborah Andrews | BIOTIME | 61 | |
| Chase Leavitt | BIOTIME | 37 | |
| Michael Mulroy | BIOTIME | 53 | |
| Oliver Olbrich | TELES Informationstechnologien | 59 | |
| Alfred Kingsley | BIOTIME | 76 | |
| Gary Hogge | BIOTIME | 51 | |
| Angus Russell | BIOTIME | 63 | |
| Edward Wirth | BIOTIME | 53 | |
| Neal Bradsher | BIOTIME | 53 | |
| Alexandra Hernandez | BIOTIME | N/A | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0643 |
ConvaTec Group PLC Leadership Team
Elected by the shareholders, the ConvaTec Group's board of directors comprises two types of representatives: ConvaTec Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ConvaTec. The board's role is to monitor ConvaTec Group's management team and ensure that shareholders' interests are well served. ConvaTec Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ConvaTec Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karim Bitar, Chief Executive Officer, Executive Director | ||
| John Lindskog, President and Chief Operating Officer, Global Infusion Care | ||
| Donal Balfe, Executive Vice President - Global Quality, Operations and Regulatory | ||
| Christian Hoengaard, VP USA | ||
| Heather Mason, Non-Executive Director | ||
| Mani Gopal, President and Chief Operating Officer, Global Ostomy Care | ||
| Supratim Bose, President and Chief Operating Officer, Global Emerging Markets | ||
| Adam Deutsch, Executive Vice President General Counsel and Corporate Development | ||
| Evelyn JD, EVP Officer | ||
| Constantin Freng, Non-Executive Director | ||
| Sten Scheibye, Non-Executive Director | ||
| Seth Segel, President Home Services Group | ||
| Frank Schulkes, Chief Financial Officer, Executive Director | ||
| Fiona Ryder, CFO Controller | ||
| Natalia Kozmina, Ex Officer | ||
| David Shepherd, President Care | ||
| James Kerton, General EVP | ||
| Clare Bates, Company Secretary | ||
| Mark Reynolds, Director Relations | ||
| Kjersti Grimsrud, President and Chief Operating Officer, Global Continence Care | ||
| Rick Anderson, Non-Executive Director | ||
| Margaret Ewing, Senior Non-Executive Independent Director | ||
| Divakar Ramakrishnan, Chief Technology Officer | ||
| Kate Postans, VP Communications | ||
| Rosalind Rivaz, Non-Executive Independent Director | ||
| John Haller, Executive Officer | ||
| Sean McGrath, Executive Vice President - Global Human Resources | ||
| Jonathan Mason, Group Director | ||
| Regina Benjamin, Non-Executive Independent Director | ||
| Brian May, Non-Executive Independent Director | ||
| David Shepherda, President and Chief Operating Officer, Global Advanced Wound Care | ||
| John McAdam, Independent Non-Executive Chairman of the Board | ||
| MSc Biotechnology, President Care | ||
| Emma Rose, EVP Officer |
ConvaTec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ConvaTec Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0643 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 6.11 B | ||||
| Shares Outstanding | 1.95 B | ||||
| Shares Owned By Insiders | 0.42 % | ||||
| Shares Owned By Institutions | 75.94 % | ||||
| Price To Earning | 51.74 X | ||||
| Price To Book | 3.32 X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in ConvaTec Stock
ConvaTec Group financial ratios help investors to determine whether ConvaTec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ConvaTec with respect to the benefits of owning ConvaTec Group security.